These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25047677)
1. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort. Prieto-Alhambra D; Lalmohamed A; Abrahamsen B; Arden NK; de Boer A; Vestergaard P; de Vries F Arthritis Rheumatol; 2014 Nov; 66(11):3233-40. PubMed ID: 25047677 [TBL] [Abstract][Full Text] [Related]
2. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Prieto-Alhambra D; Javaid MK; Judge A; Murray D; Carr A; Cooper C; Arden NK BMJ; 2011 Dec; 343():d7222. PubMed ID: 22147909 [TBL] [Abstract][Full Text] [Related]
3. Postoperative Bisphosphonates Use is Associated with Reduced Adverse Outcomes After Primary Total Joint Arthroplasty of Hip and Knee: A Nationwide Population-Based Cohort Study. Shih JT; Tan TL; Shen PH; Yeh TT; Wu CC; Pan RY; Chien WC; Chung CH; Wang SH Calcif Tissue Int; 2024 May; 114(5):451-460. PubMed ID: 38492035 [TBL] [Abstract][Full Text] [Related]
4. The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate. Ro DH; Jin H; Park JY; Lee MC; Won S; Han HS Knee Surg Sports Traumatol Arthrosc; 2019 Jul; 27(7):2082-2089. PubMed ID: 30547306 [TBL] [Abstract][Full Text] [Related]
5. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry. Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan. Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379 [TBL] [Abstract][Full Text] [Related]
7. Initiation of Bisphosphonates Prior to Total Joint Arthroplasty Does Not Lower Periprosthetic Fracture Risk. Lee A; Durst CR; Rajaee SS J Arthroplasty; 2024 Jun; 39(6):1459-1462. PubMed ID: 38070715 [TBL] [Abstract][Full Text] [Related]
8. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Thillemann TM; Pedersen AB; Mehnert F; Johnsen SP; Søballe K Bone; 2010 Apr; 46(4):946-51. PubMed ID: 20102756 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Cooper C; Arden NK; Ann Rheum Dis; 2015 Mar; 74(3):557-63. PubMed ID: 24451241 [TBL] [Abstract][Full Text] [Related]
10. Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; de Vries F; Cooper C; Arden NK Arthritis Rheum; 2011 Apr; 63(4):992-1001. PubMed ID: 21452321 [TBL] [Abstract][Full Text] [Related]
11. Outcomes After Metal-on-metal Hip Revision Surgery Depend on the Reason for Failure: A Propensity Score-matched Study. Matharu GS; Judge A; Murray DW; Pandit HG Clin Orthop Relat Res; 2018 Feb; 476(2):245-258. PubMed ID: 29529653 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis. Prieto-Alhambra D; Javaid MK; Judge A; Maskell J; Kiran A; Cooper C; Arden NK Osteoporos Int; 2011 May; 22(5):1555-71. PubMed ID: 20694456 [TBL] [Abstract][Full Text] [Related]
13. Effect of bisphosphonates on knee replacement surgery. Neogi T; Li S; Peloquin C; Misra D; Zhang Y Ann Rheum Dis; 2018 Jan; 77(1):92-97. PubMed ID: 28988204 [TBL] [Abstract][Full Text] [Related]
14. The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case-control study. Thillemann TM; Pedersen AB; Mehnert F; Johnsen SP; Søballe K J Bone Joint Surg Am; 2010 May; 92(5):1063-72. PubMed ID: 20439650 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate Use and Risk of Implant Revision after Total Hip/Knee Arthroplasty: A Meta-Analysis of Observational Studies. Teng S; Yi C; Krettek C; Jagodzinski M PLoS One; 2015; 10(10):e0139927. PubMed ID: 26444555 [TBL] [Abstract][Full Text] [Related]
16. Cementless total hip arthroplasty in Paget's disease of bone: a retrospective review. Wegrzyn J; Pibarot V; Chapurlat R; Carret JP; Béjui-Hugues J; Guyen O Int Orthop; 2010 Dec; 34(8):1103-9. PubMed ID: 19669762 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates and mortality: confounding in observational studies? Bergman J; Nordström A; Hommel A; Kivipelto M; Nordström P Osteoporos Int; 2019 Oct; 30(10):1973-1982. PubMed ID: 31367949 [TBL] [Abstract][Full Text] [Related]
18. Does Perioperative Use of Bisphosphonate Affect the Implant Revision Rate of Total Ankle Arthroplasty? Lee DO; Jeon YJ; Park GY; Lee DY Foot Ankle Int; 2023 Jul; 44(7):656-664. PubMed ID: 37102369 [TBL] [Abstract][Full Text] [Related]
19. Local bisphosphonate reduces migration and formation of radiolucent lines adjacent to cemented acetabular components. Schilcher J; Palm L; Ivarsson I; Aspenberg P Bone Joint J; 2017 Mar; 99-B(3):317-324. PubMed ID: 28249970 [TBL] [Abstract][Full Text] [Related]
20. Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers. Cordtz RL; Zobbe K; Højgaard P; Kristensen LE; Overgaard S; Odgaard A; Lindegaard H; Dreyer L Ann Rheum Dis; 2018 Feb; 77(2):281-288. PubMed ID: 29097373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]